Aurobindo adds ex Ranbaxy exec; Recipharm to make drug for RedHill;

> Aurobindo has named former Ranbaxy Laboratories exec Sanjeev Dani as chief operating officer and head of formulation business. Story

> Recipharm has an agreement to manufacture RedHill Biopharma's RHB-105 for the treatment of H. pylori infection. Release

> Steven Yoder, after a nearly 30 years with film coating company Colorcon, has been named to head business development for TruTag Technologies, makers of an edible tracking technology for pharmaceuticals. Release

> China's WuXi PharmaTech ($WX) says its small-molecule process development and manufacturing subsidiary Shanghai SynTheAll Pharmaceutical has gotten approval from Japan's PMDA to produce an intemediate of a branded commercial drug. Release

Suggested Articles

Lonza CEO Marc Funk is leaving for "personal reasons" after less than a year in the top job. 

Drugmakers have voluntarily recalled their generic Zantac from the U.S. market after the FDA raised concerns, but it has not been without a cost.

Just weeks after selling the sterile manufacturing assets of its Kyowa operation in Japan, it has unloaded the rest of its Kyowa drugmaking operation.